ダルトロバン

Daltroban

HCID 54343CAS 79094-20-5

基本情報

標準SMILES
O=C(O)Cc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1
InChIKey
IULOBWFWYDMECP-UHFFFAOYSA-N
分子式
C16H16ClNO4S
平均分子量
353.8 g/mol
単同位体質量
353.04885667

概要

Daltroban is a small molecule drug. Daltroban has a monoisotopic molecular weight of 353.05 Da.

名称と識別子

優先名称
Daltroban
IUPAC
2-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]acetic acid
現地名
ダルトロバン
英語名
Daltroban
分子式
C16H16ClNO4S
分子量
353.82

名称と別名

DALTROBAN79094-20-5BM-13505DaltrobanumSKF-96148SKF 961482-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]acetic acidBM 13.505SK&F 96148DTXSID6046501S25VDY08ZCSKF96148
名称をさらに表示
ダルトロバン4-[2-[[(4-クロロフェニル)スルホニル]アミノ]エチル]ベンゼン酢酸塩化ダテリプチウム2-{4-[2-(4-クロロベンゼンスルホンアミド)エチル]フェニル}酢酸Daltroban USP/EP/BPDatelliptiumChlorideDaltroban >98% (HPLC)Daltroban, 10 mM in DMSO4-[2-(4-Chlorobenzene-sulfonamido)ethyl]benzeneacetic acid4-[2-[(4-CHLOROPHENYLSULFONYL)AMINO]ETHYL]BENZENEACETIC ACID2-[4-[2-(4-chlorophenyl)sulfonylaminoethyl]phenyl]acetic acid
BM13505DTXCID40265012-(4-(2-((4-chlorophenyl)sulfonylamino)ethyl)phenyl)acetic acid4-(2-(4-Chlorophenylsulfonylamino)ethyl)phenylacetic acid4-(2-(4-Chlorobenzenesulfonylamino)ethyl)benzeneacetic acidRefChem:585160635-983-0BM 13505

データベース識別子

CAS
79094-20-5
PubChem CID
54343
DTXSID
DTXSID6046501
ChEMBL
CHEMBL71685
UNII
S25VDY08ZC
EC Number
635-983-0
Nikkaji
J153.943D

物性

構造計算による物性

XLogP
2.9
極性表面積
91.9 Ų
水素結合供与体数
2
水素結合受容体数
5
回転可能結合数
7
重原子数
23

物理化学的性質

融点
132.5 · 132.5-137.4 °C(lit.)
沸点
555.3 · 555.3±60.0 °C(Predicted)
比重(密度)
1.378 · 1.378±0.06 g/cm3(Predicted)
貯蔵温度
-20 °C · Store at -20°C
溶解性
22 mg/mL、可溶 · DMSO: 22 mg/mL、可溶
酸解離定数(Pka)
4.33 · 4.33±0.10(Predicted)

安全と法規制

GHS分類

GHS Classification · 4 件

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

安全データ

wgk
3
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36/37
Hazard Classifications
Eye Irrit. 2Skin Irrit. 2STOT SE 3
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

MeSH Pharmacological Classification · 2 件

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

応用分野 · 2 件

説明Daltroban (BM 13505, SKF 96148), a specific thromboxane A2 receptor antagonist, was studied as an antithrombotic agent. Daltroban increases intracellular calcium in vascular smooth muscle cells. Daltroban shows a protective effect in reperfusion injury. The drug was licensed to Smith Kline Beecham and underwent phase III clinical trials in the UK and Germany as an antithrombotic agent but did not enter clinical trials in the USA. Besides, вaltroban was investigated in patients with an ischemic heart disorder. However, the development of daltroban has been discontinued.

使用Daltroban can be used as a2 receptor to target adipose-derived stem cell for treating ischemic diseases.

サプライヤー22 社

Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
欧利希(湖北)医药科技有限公司17316404525 17316404525 · [email protected]

関連反応

4 件

関連ノート

読み込み中…